•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student
other

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

CAM, Khaitan, Clifford Chance on Alkem's $200m IPO

Cyril Amarchand Mangaldas and Clifford Chance advised book runners Nomura Financial Advisory & Securities (India), Axis Capital, JP Morgan India and Edelweiss Financial Services on the Rs 1,350 crore initial public offer (IPO) of Indian pharma global giant Alkem Laboratories. Alkem was advised by Khaitan & Co.

CAM Mumbai capital markets partner Gaurav Gupte and Clifford Chance Singapore partner Rahul Guptan acted for the four global coordinators and lead managers.

Khaitan Mumbai partner Abhimany Bhattacharya, executive director Sudhir Bassi, principal associate Soumya Mohapatra and associates Aanchal Arora, Aayush Mohata, Abir Sarkar and Srikant Mantravedi acted for Alkem.

The IPO of 12,853,442 Rs 2 equity shares for cash at a price of INR 1,050 per Equity Share, through an offer for sale by the selling shareholders, aggregating to Rs 13,46.62 crore, according to CAM’s press release.

The generic drugs maker had filed its prospectus for the IPO with SEBI in August, reported Business Standard.

The original version of this story overstated the size of the IPO. We regret the error.

Click to show 2 comments
at your own risk
(alt+c)
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.